Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Thoracic and Cardiovascular Surgery|January 23, 2003
Primary thoracoscopic treatment of empyema in childrenGordon Cohen, Vibeke Hjortdal, Marco Ricci, et al.
American Journal of Respiratory and Critical Care Medicine|May 6, 2006
Comparison of urokinase and video-assisted thoracoscopic surgery for treatment of childhood empyemaSamatha Sonnappa, Gordon Cohen, Catherine M Owens, et al.
American Heart Journal|September 25, 2004
The Triiodothyronine for Infants and Children Undergoing Cardiopulmonary Bypass (TRICC) study: design and rationaleMichael A Portman, Collette Fearneyhough, Tom R Karl, et al.
Oncology and Therapy|July 10, 2021
Understanding Patient Experience in Biliary Tract Cancer: A Qualitative Patient Interview StudyNikunj Patel, Xandra Lie, Chad Gwaltney, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|June 11, 2021
Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview studyNikunj Patel, Joshua Maher, Xandra Lie, et al.
Circulation|September 15, 2010
Triiodothyronine Supplementation in Infants and Children Undergoing Cardiopulmonary Bypass (TRICC): a multicenter placebo-controlled randomized trial: age analysisMichael A Portman, April Slee, Aaron K Olson, et al.
The Journal of Thoracic and Cardiovascular Surgery|December 23, 2003
Improved early outcome for end-stage dilated cardiomyopathy in childrenAnne-Marie McMahon, Carin van Doorn, Michael Burch, et al.
Lancet (London, England)|December 20, 2003
The waiting game: bridging to paediatric heart transplantationAllan P Goldman, Jane Cassidy, Marc de Leval, et al.
The Lancet. Oncology|May 2, 2024
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trialHoward A Burris, Takuji Okusaka, Arndt Vogel, et al.
NEJM Evidence|February 6, 2024
Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary Tract CancerDo-Youn Oh, Aiwu Ruth He, Shukui Qin, et al.
Pageof 3